Capricor Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Name: Capricor Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: Capricor Therapeutics Inc
Rating: 1.94608325
Author: Trendlyne DVM scores

about

Capricor Therapeutics Inc is a clinical-stage biotechnology company focused on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (DMD), a rare form of muscular dystrophy which results in mu...

24.30 0.26 (1.08%)

39.81% Fall from 52W High

195.4K

XNAS Volume

XNAS 16 Jan, 2026 10:53 AM (EST)

Not Eligible

Expensive Valuation

4.3 / 100

Technically Bullish

73.5 / 100

1Yr Price target upside is 109%

10 analysts

Capricor Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Capricor Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Capricor Therapeutics Inc is a clinical-stage biotechnology company focused on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (DMD), a rare form of muscular dystrophy which results in mu...

39.81% Fall from 52W High

SWOT Analysis

Capricor Therapeutics Inc Live Price Chart